Delayed
Japan Exchange
11:30:00 02/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1,251
JPY
|
+7.84%
|
|
+7.75%
|
-0.95%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,46,997
|
1,09,275
|
1,12,574
|
82,566
|
71,375
|
93,737
|
-
|
-
|
Enterprise Value (EV)
1 |
1,48,811
|
1,11,095
|
1,09,049
|
74,002
|
59,122
|
91,264
|
73,802
|
71,918
|
P/E ratio
|
19
x
|
14.1
x
|
56.2
x
|
11
x
|
10.4
x
|
12.3
x
|
11
x
|
11.4
x
|
Yield
|
1.59%
|
2.13%
|
3.5%
|
3.7%
|
4.15%
|
3.45%
|
3.22%
|
3.38%
|
Capitalization / Revenue
|
3.23
x
|
2.11
x
|
2.2
x
|
1.6
x
|
1.38
x
|
1.78
x
|
1.74
x
|
1.71
x
|
EV / Revenue
|
3.27
x
|
2.15
x
|
2.13
x
|
1.44
x
|
1.14
x
|
1.78
x
|
1.37
x
|
1.31
x
|
EV / EBITDA
|
12.7
x
|
9.5
x
|
8.93
x
|
6.39
x
|
4.77
x
|
7.38
x
|
5.69
x
|
5.7
x
|
EV / FCF
|
-50.8
x
|
41.5
x
|
10.4
x
|
8.12
x
|
5.51
x
|
11
x
|
11.5
x
|
11.2
x
|
FCF Yield
|
-1.97%
|
2.41%
|
9.57%
|
12.3%
|
18.2%
|
9.11%
|
8.69%
|
8.95%
|
Price to Book
|
3.16
x
|
2.13
x
|
2.19
x
|
1.5
x
|
1.27
x
|
1.57
x
|
1.48
x
|
1.38
x
|
Nbr of stocks (in thousands)
|
80,414
|
80,231
|
80,353
|
80,396
|
77,920
|
74,929
|
-
|
-
|
Reference price
2 |
1,828
|
1,362
|
1,401
|
1,027
|
916.0
|
1,251
|
1,251
|
1,251
|
Announcement Date
|
26/04/19
|
12/05/20
|
07/05/21
|
11/05/22
|
10/05/23
|
01/05/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
45,525
|
51,761
|
51,286
|
51,469
|
51,750
|
51,384
|
54,000
|
54,867
|
EBITDA
1 |
11,702
|
11,698
|
12,207
|
11,584
|
12,403
|
12,363
|
12,975
|
12,617
|
EBIT
1 |
10,526
|
10,434
|
10,367
|
9,973
|
10,837
|
10,892
|
11,200
|
11,411
|
Operating Margin
|
23.12%
|
20.16%
|
20.21%
|
19.38%
|
20.94%
|
21.2%
|
20.74%
|
20.8%
|
Earnings before Tax (EBT)
1 |
10,801
|
10,425
|
4,540
|
10,041
|
9,789
|
10,575
|
-
|
11,477
|
Net income
1 |
7,723
|
7,748
|
2,000
|
7,484
|
6,891
|
7,515
|
8,000
|
8,210
|
Net margin
|
16.96%
|
14.97%
|
3.9%
|
14.54%
|
13.32%
|
14.63%
|
14.81%
|
14.96%
|
EPS
2 |
96.05
|
96.55
|
24.91
|
93.13
|
88.22
|
98.73
|
113.6
|
109.6
|
Free Cash Flow
1 |
-2,927
|
2,677
|
10,436
|
9,115
|
10,736
|
7,214
|
6,412
|
6,438
|
FCF margin
|
-6.43%
|
5.17%
|
20.35%
|
17.71%
|
20.75%
|
14.12%
|
11.87%
|
11.73%
|
FCF Conversion (EBITDA)
|
-
|
22.88%
|
85.49%
|
78.69%
|
86.56%
|
57.18%
|
49.42%
|
51.03%
|
FCF Conversion (Net income)
|
-
|
34.55%
|
521.8%
|
121.79%
|
155.8%
|
89.37%
|
80.16%
|
78.42%
|
Dividend per Share
2 |
29.00
|
29.00
|
49.00
|
38.00
|
38.00
|
42.00
|
40.25
|
42.25
|
Announcement Date
|
26/04/19
|
12/05/20
|
07/05/21
|
11/05/22
|
10/05/23
|
01/05/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
24,173
|
24,453
|
12,518
|
25,130
|
13,879
|
12,460
|
12,969
|
12,520
|
25,489
|
13,009
|
13,252
|
12,954
|
12,178
|
25,132
|
13,170
|
13,082
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
4,851
|
4,369
|
2,362
|
4,681
|
2,823
|
2,469
|
2,707
|
2,412
|
5,119
|
2,812
|
2,906
|
3,176
|
2,296
|
5,472
|
2,978
|
2,442
|
2,950
|
2,800
|
5,600
|
3,000
|
2,900
|
Operating Margin
|
20.07%
|
17.87%
|
18.87%
|
18.63%
|
20.34%
|
19.82%
|
20.87%
|
19.27%
|
20.08%
|
21.62%
|
21.93%
|
24.52%
|
18.85%
|
21.77%
|
22.61%
|
18.67%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
4,841
|
4,007
|
2,393
|
4,811
|
2,706
|
2,524
|
2,670
|
2,439
|
5,109
|
1,584
|
3,096
|
3,240
|
2,386
|
5,626
|
2,959
|
1,990
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
3,555
|
2,784
|
1,889
|
3,591
|
1,931
|
1,962
|
1,946
|
1,756
|
3,702
|
869
|
2,320
|
2,330
|
1,703
|
4,033
|
2,140
|
1,342
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
14.71%
|
11.39%
|
15.09%
|
14.29%
|
13.91%
|
15.75%
|
15.01%
|
14.03%
|
14.52%
|
6.68%
|
17.51%
|
17.99%
|
13.98%
|
16.05%
|
16.25%
|
10.26%
|
-
|
-
|
-
|
-
|
-
|
EPS
|
44.29
|
34.68
|
23.49
|
44.67
|
24.02
|
24.44
|
24.73
|
-
|
47.27
|
11.20
|
-
|
30.03
|
-
|
52.41
|
28.29
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
38.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/11/19
|
28/10/20
|
01/11/21
|
01/11/21
|
28/01/22
|
11/05/22
|
29/07/22
|
02/11/22
|
02/11/22
|
01/02/23
|
10/05/23
|
02/08/23
|
06/11/23
|
06/11/23
|
02/02/24
|
01/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,814
|
1,820
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
3,525
|
8,564
|
12,253
|
14,563
|
19,934
|
21,818
|
Leverage (Debt/EBITDA)
|
0.155
x
|
0.1556
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2,927
|
2,677
|
10,436
|
9,115
|
10,736
|
7,214
|
6,412
|
6,438
|
ROE (net income / shareholders' equity)
|
17.6%
|
15.8%
|
3.9%
|
14.1%
|
12.4%
|
13.2%
|
13.5%
|
13.2%
|
ROA (Net income/ Total Assets)
|
16.8%
|
14.6%
|
14.2%
|
13.7%
|
14.8%
|
14.3%
|
12.6%
|
12.6%
|
Assets
1 |
46,005
|
53,059
|
14,066
|
54,665
|
46,710
|
52,611
|
63,745
|
65,155
|
Book Value Per Share
2 |
578.0
|
641.0
|
638.0
|
683.0
|
721.0
|
775.0
|
844.0
|
906.0
|
Cash Flow per Share
2 |
112.0
|
115.0
|
47.80
|
117.0
|
112.0
|
122.0
|
131.0
|
138.0
|
Capex
1 |
1,712
|
2,472
|
996
|
1,516
|
1,706
|
2,791
|
2,305
|
2,339
|
Capex / Sales
|
3.76%
|
4.78%
|
1.94%
|
2.95%
|
3.3%
|
5.46%
|
4.27%
|
4.26%
|
Announcement Date
|
26/04/19
|
12/05/20
|
07/05/21
|
11/05/22
|
10/05/23
|
01/05/24
|
-
|
-
|
Last Close Price
1,251
JPY Average target price
1,333
JPY Spread / Average Target +6.58% Consensus |
1st Jan change
|
Capi.
|
---|
| -0.95% | 613M | | +9.68% | 125B | | -7.58% | 10.91B | | +2.17% | 8.93B | | +22.75% | 7.57B | | +33.99% | 5.36B | | +8.12% | 3.43B | | -8.48% | 2.81B | | -5.07% | 2.23B | | -4.22% | 2.13B |
Medical Devices & Implants
|